Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-436,100
Closed -$54.6M 5001
2025
Q4
$54.6M Buy
436,100
+406,000
+1,349% +$51.7M 0.01% 736
2025
Q3
$4.03M Buy
30,100
+200
+0.7% +$26.3K ﹤0.01% 2360
2025
Q2
$4.07M Sell
29,900
-46,400
-61% -$6.12M ﹤0.01% 2298
2025
Q1
$10.1M Buy
76,300
+25,700
+51% +$3.27M ﹤0.01% 1395
2024
Q4
$5.72M Buy
50,600
+45,000
+804% +$5.2M ﹤0.01% 2027
2024
Q3
$638K Sell
5,600
-404,000
-99% -$44.3M ﹤0.01% 3625
2024
Q2
$42.6M Buy
+409,600
New +$43.4M 0.01% 667
2024
Q1
Sell
-30,800
Closed -$3.39M 5037
2023
Q4
$3.39M Buy
30,800
+20,800
+208% +$2.08M ﹤0.01% 2451
2023
Q3
$969K Sell
10,000
-84,000
-89% -$8.82M ﹤0.01% 2360
2023
Q2
$10.2M Buy
+94,000
New +$10M 0.01% 980
2022
Q1
Sell
-307,700
Closed -$43.3M 4879
2021
Q4
$43.3M Buy
+307,700
New +$39.4M 0.02% 637
2021
Q1
Sell
-146,500
Closed -$16M 4633
2020
Q4
$16M Hold
146,500
0.01% 929
2020
Q3
$15.9M Sell
146,500
-59,900
-29% -$6.08M 0.01% 844
2020
Q2
$18.9M Sell
206,400
-6,100
-3% -$551K 0.01% 666
2020
Q1
$16.8M Sell
212,500
-153,500
-42% -$12.8M 0.01% 717
2019
Q4
$31.8M Buy
366,000
+73,100
+25% +$6.12M 0.02% 709
2019
Q3
$24.5M Sell
292,900
-79,000
-21% -$6.71M 0.02% 770
2019
Q2
$31.3M Buy
371,900
+700
+0.2% +$55.1K 0.02% 690
2019
Q1
$29.7M Sell
371,200
-403,200
-52% -$30M 0.02% 655
2018
Q4
$56M Buy
774,400
+130,100
+20% +$9.14M 0.04% 344
2018
Q3
$47.3M Buy
644,300
+175,300
+37% +$11.5M 0.03% 434
2018
Q2
$28.6M Buy
469,000
+161,600
+53% +$9.8M 0.02% 608
2018
Q1
$18.4M Sell
307,400
-197,100
-39% -$11.9M 0.01% 888
2017
Q4
$28.8M Buy
504,500
+46,200
+10% +$2.56M 0.02% 620
2017
Q3
$24.5M Sell
458,300
-4,400
-1% -$221K 0.03% 579
2017
Q2
$22.5M Buy
462,700
+252,700
+120% +$11.4M 0.02% 552
2017
Q1
$9.33M Sell
210,000
-50,600
-19% -$2.19M 0.01% 918
2016
Q4
$10M Sell
260,600
-103,400
-28% -$4.1M 0.01% 941
2016
Q3
$15.4M Buy
364,000
+5,900
+2% +$253K 0.02% 653
2016
Q2
$14.1M Buy
358,100
+63,000
+21% +$2.51M 0.02% 671
2016
Q1
$12.1M Sell
295,100
-228,000
-44% -$9.03M 0.02% 678
2015
Q4
$23M Buy
523,100
+15,400
+3% +$680K 0.03% 522
2015
Q3
$20.3M Sell
507,700
-174,100
-26% -$8.21M 0.02% 593
2015
Q2
$33.4M Buy
681,800
+139,100
+26% +$6.68M 0.04% 430
2015
Q1
$25M Buy
542,700
+41,000
+8% +$1.88M 0.03% 580
2014
Q4
$22.6M Sell
501,700
-105,000
-17% -$4.57M 0.02% 699
2014
Q3
$24.9M Buy
606,700
+131,000
+28% +$5.54M 0.02% 615
2014
Q2
$19M Sell
475,700
-28,900
-6% -$1.13M 0.02% 724
2014
Q1
$19.2M Buy
504,600
+2,800
+0.6% +$108K 0.02% 718
2013
Q4
$19.1M Buy
501,800
+278,600
+125% +$10.3M 0.02% 790
2013
Q3
$7.37M Sell
223,200
-353,500
-61% -$12.4M 0.01% 1386
2013
Q2
$20.1M Buy
+576,700
New +$21.2M 0.03% 642

Other funds holding ABT

Barclays's ABT Position: Q1 2026 in Review

Barclays increased its Abbott (ABT) stake by 22% in Q1 2026, buying an estimated $78.4M and bringing the position to 3,876,707 shares worth $398M. The position accounts for 0.1% of the portfolio, ranked #154.

Barclays first reported a position in ABT in Q2 2013 and has held it in 52 quarters since. The position peaked at $798M in Q2 2024. 3,087 funds tracked by Wall St. Rank hold ABT as of Q1 2026.

  • Barclays held 3,876,707 shares of Abbott worth $398M as of Q1 2026.
  • Barclays bought 694,388 Abbott shares in Q1 2026, an estimated $78.4M.
  • Abbott made up 0.1% of Barclays's portfolio in Q1 2026, its #154 holding.
  • Barclays first reported a position in Abbott in Q2 2013 and has held it in 52 quarters since.
  • Barclays's Abbott position peaked at $798M in Q2 2024.
  • 3,087 funds tracked by Wall St. Rank held Abbott as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.